Bellevue Group Ag Amgen Inc Transaction History

Bellevue Group Ag

$5.98 Billion
Q2 2024

A detailed history of Bellevue Group Ag transactions in Amgen Inc stock. As of the latest transaction made, Bellevue Group Ag holds 29,528 shares of AMGN stock, worth $9.33 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

29,528

Previous 22,139 33.38%

Holding current value

$9.33 Million

Previous $6.29 Million 46.58%

% of portfolio

0.15%

Previous 0.1%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$262.75 - $319.31 $1.94 Million - $2.36 Million	7,389 Added 33.38%	29,528 $9.23 Million
Q1 2024 May 15, 2024	SELL	$268.87 - $324.56 $3.24 Million - $3.92 Million	-12,066 Reduced 35.28%	22,139 $6.29 Million
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $3.65 Million - $4.12 Million	-14,268 Reduced 29.43%	34,205 $9.85 Million
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $4.63 Million - $5.74 Million	21,163 Added 77.49%	48,473 $13 Million
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $2.37 Million - $2.8 Million	-11,057 Reduced 28.82%	27,310 $6.06 Million
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $129,151 - $157,414	-572 Reduced 1.47%	38,367 $9.28 Million
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $1.43 Million - $1.82 Million	-6,257 Reduced 13.84%	38,939 $10.2 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $1.29 Million - $1.46 Million	-5,763 Reduced 11.31%	45,196 $10.2 Million
Q2 2022 Aug 11, 2022	SELL	$230.71 - $256.74 $655,447 - $729,398	-2,841 Reduced 5.28%	50,959 $12.4 Million
Q1 2022 May 13, 2022	SELL	$219.27 - $242.57 $953,824 - $1.06 Million	-4,350 Reduced 7.48%	53,800 $13 Million
Q4 2021 Feb 10, 2022	BUY	$198.88 - $227.6 $4.81 Million - $5.51 Million	24,200 Added 71.28%	58,150 $13.1 Million
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $20.3 Million - $23.8 Million	-95,630 Reduced 73.8%	33,950 $7.22 Million
Q2 2021 Aug 12, 2021	SELL	$233.58 - $259.14 $10.9 Million - $12.1 Million	-46,860 Reduced 26.56%	129,580 $31.6 Million
Q1 2021 May 12, 2021	SELL	$221.91 - $258.6 $9.22 Million - $10.7 Million	-41,550 Reduced 19.06%	176,440 $43.9 Million
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $8.3 Million - $9.89 Million	38,377 Added 21.37%	217,990 $50.1 Million
Q3 2020 Nov 16, 2020	BUY	$234.65 - $260.95 $2.73 Million - $3.04 Million	11,650 Added 6.94%	179,613 $45.7 Million
Q2 2020 Aug 13, 2020	BUY	$197.81 - $242.74 $7.2 Million - $8.83 Million	36,390 Added 27.66%	167,963 $39.6 Million
Q1 2020 May 14, 2020	BUY	$182.24 - $241.7 $16.6 Million - $22 Million	91,223 Added 226.08%	131,573 $26.7 Million
Q4 2019 Feb 14, 2020	SELL	$189.21 - $243.2 $3.28 Million - $4.22 Million	-17,350 Reduced 30.07%	40,350 $9.73 Million
Q3 2019 Nov 14, 2019	BUY	$174.11 - $208.62 $1.93 Million - $2.32 Million	11,100 Added 23.82%	57,700 $11.2 Million
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $5.35 Million - $6.27 Million	32,100 Added 221.38%	46,600 $8.59 Million
Q1 2019 May 15, 2019	SELL	$180.87 - $203.88 $5.51 Million - $6.21 Million	-30,450 Reduced 67.74%	14,500 $2.76 Million
Q4 2018 Feb 12, 2019	BUY	$178.4 - $208.25 $1.43 Million - $1.67 Million	8,000 Added 21.65%	44,950 $8.75 Million
Q3 2018 Nov 13, 2018	SELL	$185.29 - $208.89 $2.03 Million - $2.29 Million	-10,950 Reduced 22.86%	36,950 $7.66 Million
Q2 2018 Aug 07, 2018	SELL	$166.05 - $186.51 $3.45 Million - $3.88 Million	-20,800 Reduced 30.28%	47,900 $8.84 Million
Q1 2018 May 09, 2018	SELL	$169.43 - $198.0 $2.21 Million - $2.58 Million	-13,050 Reduced 15.96%	68,700 $11.7 Million
Q4 2017 Feb 14, 2018	SELL	$168.79 - $188.59 $19.7 Million - $22 Million	-116,895 Reduced 58.85%	81,750 $14.2 Million
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $5.84 Million - $6.67 Million	34,917 Added 21.33%	198,645 $37 Million
Q2 2017 Aug 14, 2017	BUY	N/A	163,728	163,728 $28.2 Million

Others Institutions Holding AMGN

# of Institutions

3,073

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.

Account

Bellevue Group Ag Amgen Inc Transaction History